Document is current
Any future updates will be listed below
-
Authors
Schell, Bérénice
Zhao, Lin-Pierre
M’Sibih, Inés
Kalogeraki, Maria
Kergaravat, Camille
Lereclus, Emilie
Fenaux, Pierre
Adès, Lionel
Toubert, Antoine
Espéli, Marion
Balabanian, Karl
Clave, Emmanuel
Dulphy, Nicolas
Bisio, Valeria
-
Funding
Funding for this research was provided by:
Association Force Hémato
French Ministry of Health and the French National Cancer Institute (PRT-K2017-109, PRT-K2017-109, PRT-K2017-109)
IHU THEMA
ITMO Cancer of Aviesan
Cancéropôle Ile-de-France
Association Laurette Fugain (ALF 2016-07)
Ligue contre le Cancer
Fondation de France
- License Information
-
More Information
Article History
Received: 19 September 2024
Accepted: 17 June 2025
First Online: 2 July 2025
Declarations
:
: Bérénice SCHELL, Lin-Pierre ZHAO, Antoine TOUBERT, Marion ESPELI, Karl BALABANIAN, Nicolas DULPHY, Valeria BISIO and the French National Institute of Health and Medical Research (INSERM) declare pending patent application (#EP23306658.8) relating to the AMO system. All other authors have no competing interest.
